Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool November 3, 2009 Morgan Housel	Buffett Bags His Elephant A closer look at the Burlington Northern/Berkshire Hathaway deal.
The Motley Fool October 15, 2007 Morgan Housel	Buffett's Railroad Purchases Stay on Track The Berkshire Hathaway chief's continued buying spree sheds some light on a once dormant industry. Is it time for investors to jump in?
The Motley Fool August 12, 2009 Brian Orelli	The Next Big Thing Is Not Right in Front of You Perhaps the fastest evolving technology right now is found in DNA sequencing.
The Motley Fool November 29, 2011	A Brief History of Union Pacific's Returns Union Pacific's P/E ratio has stayed in a fairly tight range over the last 10 years.
The Motley Fool May 28, 2010 Brian Orelli	Is It Time to Make Money Investing in Genetic Testing? Easier said than done.
The Motley Fool January 20, 2006 Stephen D. Simpson	More Workin' Needed on This Railroad Union Pacific is still the worst-run major railroad, but improvement could lead to outperformance in its stock.
The Motley Fool November 26, 2010 Palash R. Ghosh	Railway Stocks on Track for Long-Term Growth Buffett's buy created some interest, but the industry remains underfollowed -- and undervalued.
The Motley Fool August 30, 2007 David Lee Smith	Warren Buffett's Expanding Railroad Ties Warren Buffett now has a boxcar full of shares in Burlington Northern Santa Fe. Investors, take note.
BusinessWeek May 12, 2011 Mark Clothier	Warren Buffett's Ride on the Rails Is Paying Off During the recession, Warren Buffett bet more than $26 billion on a revival in railroads. A year later, business is gathering momentum.
The Motley Fool August 19, 2011 Alexander Crawford	DNA Sequencing: The Next High-Growth Market in Biotech? We compiled a list of companies with a hand in the DNA sequencing market. Should you add these companies to your watch list?
The Motley Fool February 18, 2010 Rich Smith	What in the World Is Warren Buffett Thinking? You heard it here first: The recession ain't over. Berkshire filed its quarterly Form 13F-HR with the SEC, revealing a multitude of tweaks and fine-tunings to the Master's portfolio.
The Motley Fool July 28, 2010 Brian Orelli	Now There's an Illuminating Idea Helping your customers sell more of your product makes a lot of sense.
The Motley Fool October 25, 2011 Alex Pape	High Oil Prices Benefit This Niche Industry Don't overlook the intermodal transportation industry.
The Motley Fool November 19, 2009 Alice Schroeder	Buffett, Railroads, and the Lessons of History The author of The Snowball: Warren Buffett and the Business of Life, analyzes the Oracle's biggest deal ever.
Chemistry World May 29, 2014 Hepeng Jia	Chinese-made DNA sequencer aims to challenge foreign dominance With an independently developed next-generation DNA sequencer, Chinese scientists are aiming to challenge the dominance of international players in the world's fastest growing genome sequencing market.
The Motley Fool July 24, 2008 Brian Orelli	Illumina Polishes Its Biochips There's very little to complain about in Illumina's earnings report. In this market, you'll see few investors grumbling about double-digit growth.
The Motley Fool December 14, 2009 Stephen Mauzy	Trucking Keeps On ... Well, You Know As the economy improves, so will trucking stocks.
The Motley Fool October 28, 2009 Brian Orelli	Ugly, but Still Built for Growth It continues to be a tale of two business segments for Illumina, with sales from the consumables used in its sequencing machines more than doubling, while its array business remains down considerably.
The Motley Fool April 25, 2006 Bobby Shethia	Norfolk Southern: Worth the Trip Its technology, strong service, and operating margins make this railroad the way to go for investors looking for market leaders in cyclical industries.
The Motley Fool April 10, 2007 David Lee Smith	Buffett Tracking Two More Railroads Buffett buys shares in unnamed North American railroads. Investors, take note.
BusinessWeek October 23, 2008 John Carey	Reading the Entire Genetic Code Pioneers such as 23andMe and Navigenics use snips of genes to make medical predictions. Now new tools from more start-ups are on the horizon.
The Motley Fool November 17, 2006 Jack Uldrich	Neanderthal DNA Enlightens Investors Investors, the superb performance of 454's gene sequencing equipment on such a difficult and important project bodes well for its future prospects.
The Motley Fool November 25, 2009 Rich Smith	This Just In: Upgrades and Downgrades UBS downgrades Union Pacific, citing how railroad stocks have outperformed the S&P 500 since Warren Buffett's purchase of Burlington Northern.
BusinessWeek July 24, 2006 Christopher Palmeri	Serving Two (Station) Masters More spending may assuage Burlington Northern's customers, but not Wall Street.
The Motley Fool July 27, 2009 Christopher Barker	Runaway Freight Train Finds Level Tracks Demand stabilization is a most welcome development in the rail freight sector, but a long, hard path still awaits these operators.
The Motley Fool October 27, 2009 Christopher Barker	Steep Grades Ahead for Railroads After signs of stabilization, reality sets in for a difficult recovery.
The Motley Fool April 27, 2011 Brian Orelli	Illuminating the Growth Competition in the DNA sequencing market may be heating up, but 47% growth for Illumina isn't too shabby.
The Motley Fool April 20, 2006 Stephen D. Simpson	Union Pacific Full of Steam Very strong pricing and operational improvements lead to a great quarter. Investors, take note.
The Motley Fool January 14, 2010 Brian Orelli	$1,000 Genomes, Here We Come Illumina jumps on news of its $10,000 genome.
The Motley Fool January 20, 2012 Christopher Barker	Union Pacific Rips Up the Rails Led by Union Pacific, North American railroads continue to deliver.
The Motley Fool May 30, 2008 Zoe Van Schyndel	Investing in Planes, Trains, and Ships Transportation ETFs let you benefit from an expanding global economy.
The Motley Fool March 8, 2010 Rich Smith	Clash of the Titans: Buffett vs. Goldman Sachs It's a clash of titans, and railroads are the losers.
CIO September 11, 2008 Stephanie Overby	How IT is Helping the Railroad Industry Improve Efficiency and Service Railroads are poised for a comeback, thanks to rising fuel prices. IT provides the linchpin for a shipping model that integrates ships, trucks and trains.
The Motley Fool August 18, 2010 Luke Timmerman	Life Technologies Competes for Cheap DNA Sequencing In the race to cheaper gene sequencing.
IEEE Spectrum March 2013 Eliza Strickland	The Gene Machine and Me Ion Torrent's chip-based genome sequencer is cheap, fast, and poised to revolutionize medicine
The Motley Fool January 25, 2010 Christopher Barker	Your Huge Advantage Over Warren Buffett Burlington Northern is Buffett's prize, but will retail investors take the cake?
Chemistry World February 21, 2012 Phillip Broadwith	Nanopore sequencing bags its first genome Oxford Nanopore has presented the first complete genome to be sequenced using a nanopore.
Bio-IT World September 2005 Kevin Davies	Fantastic 454: DNA Sequencing Pyrotechnics In an exciting advance for DNA sequencing technology, a research team at 454 Life Sciences Corp. has essentially sequenced and assembled a bacterial genome sequence based on a mere 4-hour run on the company's proprietary instrument.
The Motley Fool June 12, 2007 Todd Wenning	The Best Stocks Right Now Investors have spoken -- here's what they said. Genesee & Wyoming... Canadian Natural Resources... Mueller Water... Leucadia National... etc.
The Motley Fool September 12, 2008 Brian Orelli	Monsanto Makes Half a Discovery Monsanto announces that it has sequenced the DNA of one of its "top-performing elite" lines of corn.
The Motley Fool September 6, 2007 Toby Shute	Canadian Pacific Buys Like Buffett The Canadian railroad company has acquired Dakota, Minnesota & Eastern, the largest American regional railroad operator, in order to better access the bustling Midwestern coal, ethanol, and agricultural markets.
The Motley Fool April 1, 2010 Rich Duprey	Truck Stocks Keep On ... Well, You Know Trucking companies are on the road to recovery.
The Motley Fool March 30, 2007 Ralph Casale	Another Genetic Sequencer Gobbled Up Roche buys out second-generation sequencer 454 Life Sciences. Investors, take note.
The Motley Fool February 22, 2010 Rick Aristotle Munarriz	5 Stocks Over $100 Sometimes big things come in bigger packages.
CFO January 1, 2009 Edward Teach	"We Are the Green Solution" What's a few billion dollars spent on infrastructure when your vehicles get more than 700 mpg? An interview with Robert M. Knight Jr., EVP and CFO, Union Pacific Corp.
IEEE Spectrum July 2010 Prachi Patel	Computing the Neanderthal Genome New software helped decode the DNA of our stone-age cousins
The Motley Fool December 24, 2007 David Lee Smith	The Amazingly Insightful Berkshire Boys It shouldn't come as a surprise that the Berkshire Boys, Warren Buffett and Charlie Munger, saw the housing mess coming before the rest of us.
The Motley Fool July 14, 2004 Brian Gorman	Burlington Northern on Track Burlington Northern railroad foresees earnings growth of 15% to 20% for the second quarter and full year.
BusinessWeek November 6, 2006 Gene G. Marcial	Solexa's Progress Is In The Genes New technology makes Solexa a leading contender in the next-generation sequencing race.
The Motley Fool July 21, 2005 Stephen D. Simpson	Union Pacific Along for the Ride A very strong market for rail transport has improved the fortunes of even this low-quality player. But it has a way to go before the stock is a keeper.